The Divisions of Neurology and Psychiatry seek participants to take part in a voluntary research study to evaluate different medications to treat relapsing remitting forms of multiple sclerosis (MS).
Participants must be between the ages of 18 and 65, have been diagnosed with a relapsing remitting form of MS and be naive to treatment or have five years or less of total lifetime exposure to one class of disease modifying therapy (DMT).
Qualified participants will receive study-related exams and study medication at no cost.
For more information, call 855-810-3319. Refer to IRB No. 22634.